Patterns of Care (POC) Quality of Care Dx Yr 2011

护理模式 (POC) 护理质量 Dx 2011 年

• 批准号: 8565158
• 负责人: VIVIEN CHEN
• 金额: $ 6.41万
• 依托单位: LSU HEALTH SCIENCES CENTER
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-08-01 至 2013-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8565158
• 关键词: Adjuvant Therapy; Adopted; Age; Beds; Biological Markers; Cancer Patient; Characteristics; Communities; Comorbidity; Data; Diagnostic tests; Division of Cancer Control and Population Sciences; Educational process of instructing; Ethnic Origin; Geographic Locations; Hospitals; Laws; Link; Malignant Neoplasms; Malignant neoplasm of ovary; Medicare; Mesothelioma; Metastatic Melanoma; National Cancer Institute; Neuroblastoma; Operative Surgical Procedures; Pattern; Patterns of Care; Physicians; Quality of Care; Race; Radiation therapy; Reporting; Time; United States; Work; cancer therapy; chemotherapy; clinical practice; hormone therapy; oligodendroglioma; sex

SEER Patterns of Care Studies describe, characterize, and compare practice patterns and treatments provided for cancer in different geographic areas of the United States. SEER Patterns of Care Studies are conducted to satisfy a Congressional directive (under Public Law 100-607, Sec. 413 (a)(2)(C) adopted November 4, 1988) to the National Cancer Institute to ¿assess the incorporation of state-of-the-art cancer treatments into clinical practice and the extent to which cancer patients receive such treatments and include the results of such assessment in the biennial reports¿¿. To select the cancers to satisfy this directive, the Division of Cancer Control and Population Sciences has been working closely with the Division of Cancer Treatment. This year¿s Pattern¿s of Care (POC) Study will investigate state-of-the-art therapies for with metastatic melanoma, mesothelioma, astocytoma/oligodendroglioma, ovarian cancers, and neuroblastoma

预见性护理模式研究描述、描述和比较美国不同地理区域为癌症提供的实践模式和治疗方法。先知护理模式研究是为了满足国会指令(根据公法100-607，SEC.413(A)(2)(C)(1988年11月4日通过)提交给国家癌症研究所，以“评估将最先进的癌症治疗纳入临床实践的情况以及癌症患者接受这种治疗的程度，并将评估的结果纳入两年一次的报告”。为了选择符合这一指令的癌症，癌症控制和人口科学部一直与癌症治疗部密切合作。今年的S模式S研究将探索转移性黑色素瘤、间皮瘤、星形细胞瘤/少突胶质瘤、卵巢癌和神经母细胞瘤的最新治疗方法。